baber/WOPTO huggingface dataset:
Patent DK-2264385-T3 (DK)
Inventor: HEINBOKEL BERND
IPC: F25B40/06
Filed: 2005-07-29
Granted: 2018-07-23
Abstract: Refrigerant is circulated in a predetermined flow direction comprised of a heat-rejecting heat exchanger (4), intermediate throttle valve (6), receiver (8), evaporator throttle valves (10), evaporator (14), compressor (20) and flash gas tapping line (26). The flash gas tapping line is connected to the receiver and to the compressor. An independent claim is also included for a refrigeration circuit operating method.
Patent DK-2277490-T3 (DK)
Title: Wheelchair suspension
Inventor: BEKOSCKE ROBERT
IPC: A61G5/04
Filed: 2008-02-04
Granted: 2015-04-13
Abstract: A suspension for a vehicle is provided. The suspension includes, for example, a frame, at least one drive assembly, and at least one front caster pivot arm. The drive assembly and the at least one front caster pivot arm pivot about a common axis. Torque applied by the drive assembly urges the front caster upward with respect to a support surface.
Patent DK-2428519-T3 (DK)
Title: A composition for the preparation of 17-vinyl triflates as intermediates
Inventor: BURY PAUL
IPC: C07J31/00
Filed: 2005-08-23
Granted: 2015-04-13
Abstract: A compound of formula (I):   
or a pharmaceutically-acceptable salt thereof, may be made by a process including a triflating step by which a ketone of formula (II) is converted into a triflate of formula (III):   
in the presence of a base comprising a tertiary or heterocyclic amine such that the pK a  of the conjugate acid at 25 °C is within the range 5.21 to 12.
Patent DK-2522154-T3 (DK)
Inventor: BRIMHALL OWEN D
IPC: H04R25/00
Filed: 2011-01-05
Granted: 2018-01-08
Abstract: A hearing aid device is described. The device including a housing having a plurality of sides, the housing also having a first color. At least one electrical component is held within the housing. A clip removably attachable to the housing is provided. The clip has a second color. The clip covers at least a portion of the plurality of sides of the housing.
Patent DK-2917195-T3 (DK)
Inventor: DIRICO KENNETH JOHN
IPC: C07D309/10
Filed: 2013-10-22
Granted: 2018-01-15
Abstract: The present invention is directed to novel cytotoxic spliceostatin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.
Patent DK-0392148-T3 (DK)
Inventor: VAHLBRAUK KARL HEINZ
IPC: F16L27/04
Filed: 1990-02-08
Granted: 1993-02-22
Abstract: In order to avoid the specific disadvantages of screwed and welded connections of pipe ends, a plug connection is proposed in which both pipe ends (1, 2) have a collar-like expansion, provided with a bulged section (4), the sections (4) being surrounded externally by a clamping body (14) whose design is matched to these sections with a view to producing a positive closure. Inside the collar-like expansion there is a metallic core pipe (6) which externally - overlapping its end face ends - carries annular sealing elements (7) which are provided in the region of their end face ends which rest on one another with retaining pockets for a curable plastic which is partially forced out of these pockets when external pressure is exerted by means of the clamping body (14) and at the same time fills the central annular space (15) between the bulged sections (4) on the one hand and the clamping body (14) on the other hand. This results in a plug connection which has smooth walls on the inner side, can easily be assembled and is protected against axial thrust in a reliable manner. <IMAGE>
Patent DK-0431363-T3 (DK)
Inventor: GALLENSCHUETZ THOMAS
IPC: G07C9/02
Filed: 1990-11-15
Granted: 1994-04-18
Abstract: In a security revolving door assembly for persons, comprising one blocking sector (13) and one passage sector (12) or two passage sectors (12), a motor-driven revolving door (10), which can be blocked by means of a braking device controllable by an electronic control unit, is arranged in the door housing. Peripheral identification devices (46, 47) are connected to the electronic control unit. To ensure reliable entry and exit control, blocking, which cannot be overcome at certain angular positions of the revolving door (10), but which always makes it possible to leave the door housing, is provided. This is achieved by means of a blocking disk (23) which is in a rigid rotating connection with the revolving door (10) and has, in a blocking plane, at least one stop face pair (26/1-26/2, 27/1-27/2, 28/1-28/2) with two stop faces (26/1 through 28/2), each acting in one reaction direction. Two stationary locking bolts (24 and 25), which can be brought into blocking position between two stop faces (26/1 through 28/2), are associated with the blocking disk (23). Due to their special arrangement relative to the distance between two stop faces (26/1 through 28/2), the revolving door (10) is freely rotatable through half the sector angle of the passage sector (12) when the locking bolt (24, 25) has dropped in.
Patent DK-0386867-T3 (DK)
Inventor: FISCHER ADDISON M
IPC: G06Q20/00
Filed: 1990-01-11
Granted: 1995-04-03
Abstract: A public key cryptographic system is disclosed with enhanced digital signature certification which authenticates the identity of the public key holder. A hierarchy of nested certifications and signatures are employed which indicate the authority and responsibility levels of the individual whose signature is being certified. The certifier in constructing a certificate generates a special message that includes fields identifying the public key which is being certified, and the name of the certifee. The certificate is constructed by the certifier to define the authority which is being granted and which may relate to wide range of authorizations, delegation responsibilities or restrictions given to, or placed on the certifee. Methodology is also disclosed by which multiple objects such as, for example, a cover letter, an associated enclosed letter, an associated graphics files, etc, are signed together. Methodology is also disclosed for digitally signing documents in which a digital signature is generated for both computer verification and for reverification if a document needs to be reconfirmed by reentering from a paper rendition. <IMAGE>
Patent DK-0434377-T3 (DK)
Inventor: CARROLL JAMES J
IPC: G01N33/86
Filed: 1990-12-18
Granted: 1995-09-25
Abstract: A method of determining levels of extrinsic and intrinsic clotting factors and protein C based upon the reaction rate of the observed clot formation and the first derivative of the reaction rate of observed clot formation is provided. In accordance with the teachings of the invention, the reaction rate of the observed clot formation in a prothrombin time test or an activated partial thromboplastin time assay is determined for both test and normal plasma samples and the reaction rates compared. In another embodiment, the first derivative of the reaction rate of the observed clot formation is determined and the results compared.
Patent DK-0533132-T3 (DK)
Inventor: SCHARBERT BERND DR
IPC: C25B3/23
Filed: 1992-09-16
Granted: 1995-04-18
Abstract: A process for the selective oxidation of hydroxymethylpyridine derivatives of the general formula I to pyridinecarboxylic acid derivatives thereof of the formula II on nickelic hydroxide anodes is described. 
<IMAGE>
Patent DK-0577697-T3 (DK)
Inventor: MCVICKER HENRY J
IPC: B29C33/42
Filed: 1992-03-05
Granted: 2000-01-03
Abstract: An injection-molded thermoplastic device having a field of injection-molded hooks integrally formed in predetermined areas on the device during the injection-molding of the device for releasable attachment to a strap with loops.
Patent DK-0597020-T3 (DK)
Inventor: WALKER ROBERT A
IPC: F02F7/00
Filed: 1992-07-29
Granted: 1998-07-20
Abstract: The combination apparatus silences and filters air flow and separates air-contaminant mixtures. An air filter joins an annular housing which has an outer wall and a channel defining a central axis, the channel having a primary gas inlet coupled to the air filter and a primary gas outlet and a channel wall. The apparatus has a secondary inlet port passing through the outer wall. A secondary outlet port defines an opening in the channel wall such that there is no straight line flow path between the secondary inlet and the secondary outlet. An air silencer is contained within the channel. A passageway between the secondary inlet and the secondary outlet is defined exteriorly by the outer wall and interiorly by the channel wall.
Patent DK-0604566-T3 (DK)
Inventor: CHANOCK ROBERT M
IPC: C12N7/00
Filed: 1992-09-18
Granted: 2000-04-10
Abstract: The invention includes a chimeric virus for use in a vaccine preparation having a genome comprising nucleic acid sequences encoding at least one structural protein from one flavivirus and nucleic acid sequences encoding nonstructural protein from another flavivirus. The genome preferably includes mutations within the viral genome that reduce virus virulence and in a particularly preferred embodiment these vaccines are directed to flaviviruses such as dengue virus, tick-borne encephalitis virus and Japanese encephalitis virus.
Patent DK-0612238-T3 (DK)
Inventor: HOLM NIELS ERIK
IPC: A61K35/14
Filed: 1992-11-10
Granted: 1996-02-05
Abstract: PCT No. PCT/DK92/00329 Sec. 371 Date May 2, 1994 Sec. 102(e) Date May 2, 1994 PCT Filed Nov. 10, 1992 PCT Pub. No. WO93/09753 PCT Pub. Date May 27, 1993.A container for receiving and separating blood plasma into its ingredients comprises two sealingly coupled sections (1 and 2). One container section (2) and the adjacent portion of the other container section are made of solid material, and the two container sections are screwed together. The container sections (1 and 2) comprise their respective chambers (29 and 30) for receiving their respective fluid ingredients, and these chambers are interconnected through a connecting channel (31) through the abutting portions, at which the container sections (1 and 2) are screwed together. A valve seat (21, 27) is shaped at each end of the connecting channel (31) for each valve member (22, 16) for a sealing closing of the chambers (29, 30) in the separated state of the container sections (1, 2). The valve members (22, 16) comprise mutually abutting projections (23, 12) ensuring a distance between the valve members (22, 16) exceeding the distance between the associated valve seats (27, 21) in the coupled state of the container sections (1, 2), but being smaller than the distance between the associated valve seats (27, 21) in a position during a separating movement of the container sections (1, 2). Furthermore, retaining means (15, 16) are provided for ensuring that the valve members (22, 19) do not engage the valve seats (27, 21) in the coupled state of the container sections (1, 2).
Patent DK-0603453-T3 (DK)
Inventor: DEEG THOMAS DIPL-ING ETH
IPC: B63H21/30
Filed: 1993-01-07
Granted: 1996-12-16
Abstract: The intermediate shafts of a transmission with at least one torque division are braced against one another in such a way that the tooth flanks of all the meshing gearwheels (2, 5, 6, 7, 8) of the transmission engage with one another under this preload. It is thus impossible, even when the gearwheels of the transmission are idling, for the noise caused by rotary oscillations within the backlash of the gears, with the associated severe stressing of the tooth flank, to develop. Moreover, backlash-free transmission of the rotary motion is achieved without eliminating the backlach required for power transmission. This design of transmission is particularly suitable for use in marine drives with a plurality of engines. <IMAGE>
Patent DK-0570331-T3 (DK)
Inventor: MUELLER-GLAUSER WERNER
IPC: A61F2/06
Filed: 1993-04-22
Granted: 1997-12-15
Abstract: The method according to the invention represents an improvement of methods known per se for making prostheses which consist of a preshaped synthetic carrier in whose surface region endogenous cells and cell assemblages are embedded and, after the implantation, initiate a coating of the prosthesis surface or of parts of this surface with a living layer. It has emerged that even if the cells and cell assemblages to be embedded originate from a tissue which, besides these cells, also contains other cells and non-cellular tissue components, isolation of the required cells before embedding is unnecessary. For this reason it is possible according to the method according to the invention to dispense with a complicated and lengthy processing of the tissue material used to isolate the required cells, as is described for corresponding methods according to the state of the art. The tissue material is reduced in size, essentially mechanically and, if necessary, additionally enzymatically, to tissue particles whose dimensions are within limits which are as narrow as possible, and is suspended, and the preformed carrier material is treated with the suspension by the suspension being filtered through the material in the case of porous carrier material and the suspension being brought onto the surface of the carrier material by centrifugation in the case of carrier material of little or no porosity. In contrast to corresponding methods according to the state of the art, the method according to the invention can, thanks to the improvement, be carried out in very little time, that is to say directly during the operation and in a closed system.
Patent DK-0640080-T3 (DK)
Inventor: FISHER LAWRENCE E
IPC: A61P25/28
Filed: 1993-02-26
Granted: 1998-05-25
Abstract: Compounds of formula (I), (II), or (III) wherein: R<1> is lower alkyl when R<2> is V; or R<2> is lower alkyl when R<1> is V; wherein: V is (A); R<3> is hydrogen or lower alkyl; X is hydrogen, lower alkyl, halogen, -C(O)CF3, -CO2R<4>, or -C(O)NR<5>R<6>; Y is hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen, or -CO2R<4>; Z is hydrogen, lower alkyl, lower alkoxy, or halogen; with the proviso that Y and Z cannot be attached to the nitrogen atom in formula (II); in which R<4> is hydrogen or lower alkyl; R<5> is hydrogen, lower alkyl, or -CH2CO2R<4>; R<6> is hydrogen or lower alkyl; or R<5> and R<6> taken together with the nitrogen to which they are attached represent a heterocycle; R<7> is (B); (C); (D); (E); (F); (G); (H) or (J); in which: R<8> is -CO2H or 1H-tetrazol-5-yl; and W is oxygen, sulfur, or -NR-, wherein R is hydrogen or lower alkyl; and the pharmaceutically acceptable salts thereof, exhibit useful pharmacological properties, and are particularly useful as angiotensin (II) antagonists.
Patent DK-0609404-T3 (DK)
Inventor: HAUSER JEAN-LUC
IPC: A61M11/00
Filed: 1993-04-28
Granted: 1997-07-07
Abstract: PCT No. PCT/FR93/00411 Sec. 371 Date Dec. 28, 1993 Sec. 102(e) Date Dec. 28, 1993 PCT Filed Apr. 28, 1993 PCT Pub. No. WO93/22068 PCT Pub. Date Nov. 11, 1993.An acoustic micropulverization device for the formation of microdroplets is disclosed having a cell that contains a propagating medium having an attenuation less than or equal to about 1 dB/cm. One wall of the cell comprises an ultrasonic generator. Another wall of the cell contains a reflective surface that operates to focus ultrasonic waves upward toward a point that is near the top surface of a liquid that is contained in a reservoir located above the cell, thereby producing microdroplets above the liquid's top surface. A chamber is located over the top surface of the liquid. This chamber includes means for diffusing the microdroplets.
Patent DK-0693003-T3 (DK)
Inventor: RADEMACHER JOSEF
IPC: B05D7/00
Filed: 1994-03-22
Granted: 1998-04-14
Abstract: The invention relates to three-layer metal pipe coating compositions based on a powder primer, on a thermoplastic hard adhesive and on a polyolefin cladding. The powder primer contains epoxidized novolak resins, phenolic crosslinking agents and fillers based on crystalline silicic acid modifications. The invention likewise relates to a process for the exterior coating of metal pipes by a three-layer method, in which the powder primer described is applied to the metal pipe, a thermoplastic hard adhesive is applied to the powder primer, and subsequently a polyolefin cladding is applied.
Patent DK-0736018-T3 (DK)
Inventor: TANIGUCHI KIYOSHI
IPC: A61P9/00
Filed: 1994-12-16
Granted: 2000-09-18
Abstract: Heterocyclic compounds of the formula: whereinR1 is carboxy or protected carboxy, R2 is aryl which may have suitable substituent(s), R3 is aryl which may have suitable substituent(s), A1 is lower alkylene, A2 is bond or lower alkylene and -Q- is etc., and pharmaceutically acceptable salts thereof which are useful as a medicament.
Patent DK-0712322-T3 (DK)
Inventor: TANG KENNETH Y
IPC: A61B17/00
Filed: 1995-06-05
Granted: 1999-11-01
Abstract: The present invention provides an apparatus for the removal of epidermal skin cells of corneum stratum on a section of human skin, the apparatus including :   a) a light absorbing contaminant capable of infiltrating into the corneum stratum cells when applied to the skin and having a high absorption at at least one frequeny band of light ; and b) an illumination source in spaced apart relation to the contaminant when applied to a section of human skin for illuminating a surface of the section of human skin and the contaminant with pulses of light having sufficient energy to cause the tearing off of the superficial epidermal skin cells of corneum stratum.   <IMAGE>
Patent DK-0772617-T3 (DK)
Inventor: ZAEHRINGER ULRICH
IPC: A61P31/04
Filed: 1995-07-14
Granted: 1999-11-22
Abstract: PCT No. PCT/EP95/02780 Sec. 371 Date Jan. 15, 1997 Sec. 102(e) Date Jan. 15, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02550 PCT Pub. Date Feb. 1, 1996The invention describes 7-O-carbamoyl heptose derivatives of general formula (I) in which R is the substituent R1 or a group of general formula (II) in which R1 is a hydrogen atom, a methyl group or a suitable linker substituent suitable for a covalent coupling, a process for their production and their use in producing reagents and compositions for the diagnosis and therapy of pseudomona infections in humans and animals, and a screening process for their detection in Gram-negative bacteria.    <IMAGE>  (I)   <IMAGE>  (II)
Patent DK-0783314-T3 (DK)
Inventor: GERMANN PAUL-GEORG
IPC: A61K35/42
Filed: 1995-09-27
Granted: 2003-12-01
Abstract: Novel compositions for the treatment of IRDS and ARDS contain at least one glucocorticosteroid and a pulmonary surfactant. The duration of treatment with these compositions and the mortality associated with these syndromes can be significantly reduced with the administration of these compositions.
Patent DK-0882166-T3 (DK)
Inventor: EISENRING THOMAS
IPC: E04H4/00
Filed: 1997-02-10
Granted: 2003-08-04
Abstract: The invention relates to a suction and intake device for swimming pools with a frame (10) and a film (12) as the internal lining which lies around the upper edge (101) of the pool and is fastened by a slip-on connecting member (11) in the form of a handrail engaging over the film and the edge of the pool. To simplify the structure and assembly of the swimming pool, at least part of the slip-on connecting member is in the form of hollow structures (13, 14) or is used to fasten at least one hollow structure (19, 20), and the hollow structure(s) is/are constructed respectively for delivering and discharging water and/or for holding electrical incoming and outgoing cables.
Patent DK-0914339-T3 (DK)
Inventor: SANICOLA-NADEL MICHELE
IPC: A61K47/48
Filed: 1997-05-07
Granted: 2006-12-04
Abstract: This invention relates to nucleotide sequences which encode a Ret ligant (RetL9, as well as to methods of stimulating neural and renal growth by treating cells and mammalian subjects with RetL DNA or protein. The invention provides a purified and isolated DNA molecule coding for a RetL, having the nucleotide sequence of any RetL, but specifically including rat retL 1 cDNA (SEQ ID NO.1), partial human RetL1 cDNA (SEQ ID NO:8), full length human retL 1 cDNA (SEQ ID NO:10), human retL2 cDNA (SEQ ID NO:12), murine retL3 cDNA (SEQ ID NO:12) or human retL3 cDNA (SEQ ID NO;16), partial human retL3 cDNA (SEQ ID NO:18) or human retL3 cDNA (SEQ ID NO:20). The invention further provides a RetL protein, with an amino acid sequence comprising that of rat RetL1 (SEQ ID NO:2), partial human RetL1 (SEQ ID NO:9), full length human RetL (SEQ ID NO: 11), human RetL2 (SEQ ID NO:13), murine RetL3 (SEQ ID NO:17), partial human RetL3 (SEQ ID NO:19) or human RetL3 (SEQ ID NO:21).
Patent DK-1024795-T3 (DK)
Inventor: NEWTON JOHN MICHAEL
IPC: A61K47/32
Filed: 1998-10-23
Granted: 2002-12-02
Abstract: A method for producing a controlled release composition is provided. A solution of a film-forming composition comprising a mixture of a substantially water-insoluble film-forming polymer and amylose in a solvent system comprising (1) water and (2) a water-miscible organic solvent which on its own is capable of dissolving the film-forming polymer is contacted with an active material and the resulting composition dried. The weight ratio of amylose to film-forming insoluble polymer in the film-forming composition is in the range 1:2 to 3:2 and the organic solvent comprises at least 50% by weight of the solvent system. The composition is particularly suitable for delivering therapeutic agents to the colon.
Patent DK-1042340-T3 (DK)
Inventor: LIU JIH-HUA
IPC: C07H17/08
Filed: 1998-11-17
Granted: 2004-11-29
Abstract: A process of preparing a 6-O-alkyl derivative of 9-oxime erythromycin B is provided. Intermediates used in the preparation of a 6-O-alkyl 9-oxime erythromycin B are also provided. Pharmaceutical compositions containing a 6-O-alkyl derivative of 9-oxime erythromycin B and the use of those compositions to treat bacterial infections are also provided.
Patent DK-0947499-T3 (DK)
Inventor: BIGOT PATRICK
IPC: C07C231/08
Filed: 1999-03-26
Granted: 2002-06-10
Abstract: Preparation of racemic cis-N-methyl-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl amine (racemic sertraline) (I) in its salt form from 4-(3,4-dichlorophenyl)-tetralone (II) comprises: (1) reacting (II) with N-methylformamide in the presence of formic acid; (2) adding a base; and (3) separating the salt of (I) by selective crystallization with an acid. Preparation of racemic cis-N-methyl-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl amine (racemic sertraline) of formula (I) in its salt form from 4-(3,4-dichlorophenyl)-tetralone of formula (II) comprises: (1) reacting (II) with N-methylformamide in the presence of formic acid; (2) adding a base; and (3) separating the salt of (I) by selective crystallization with an acid.
Patent DK-1107938-T3 (DK)
Inventor: VON GENTZKOW WOLFGANG
IPC: C07C37/52
Filed: 1999-08-16
Granted: 2003-05-05
Abstract: A process for the feedstock recycling of thermoset materials treats the material with a partially hydrogenated aromatic hydrocarbon at a temperature of from 200 to 350° C. in the presence of an amine. In the case of epoxy resin materials an amine is not needed if processing is carried out at temperatures of from 300 to 350° C.
Patent DK-1119915-T3 (DK)
Inventor: SHIN SUNG-HYUK
IPC: H03M13/27
Filed: 1999-10-12
Granted: 2003-10-06
Abstract: A turbo code encoder with a hybrid interleaver having two recursive systematic constituent code (RSC) encoders. The system encodes a finite sequence of informative bits without requiring a plurality of tail bits to flush the registers of each encoder to an all-zero state. The hybrid interleaver reduces the turbo code overhead by using only a single tail bit sequence. By using only a single m-bit tail, the hybrid interleaver improves bit error rate (BER).
Patent ES-2224951-T3 (ES)
Inventor: FILIPPOVITCH SERGEI
IPC: B08B9/055
Filed: 2000-04-13
Granted: 2005-03-16
Abstract: The device for moving a pig through a pipeline comprises at least one pulling unit and at least one sealing unit, and is characterized by the fact that the sealing unit incorporates a carrier structure (2) with a variable periphery provided with lea one sealing element (3) made of a flexible material. An Independent claim is also included for a sealing unit as above.